Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1ELX - US5184391044 - Common Stock

88.8 EUR
+0.8 (+0.91%)
Last: 12/9/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1ELX. 1ELX was compared to 13 industry peers in the Personal Care Products industry. 1ELX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, 1ELX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ELX was profitable.
1ELX had a positive operating cash flow in the past year.
Of the past 5 years 1ELX 4 years were profitable.
In the past 5 years 1ELX always reported a positive cash flow from operatings.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

1ELX has a Return On Assets of -4.81%. This is amonst the worse of the industry: 1ELX underperforms 86.67% of its industry peers.
Looking at the Return On Equity, with a value of -23.91%, 1ELX is doing worse than 86.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.69%, 1ELX is doing worse than 73.33% of the companies in the same industry.
1ELX had an Average Return On Invested Capital over the past 3 years of 4.98%. This is significantly below the industry average of 12.37%.
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROIC 4.69%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

1ELX has a worse Operating Margin (8.72%) than 60.00% of its industry peers.
1ELX's Operating Margin has declined in the last couple of years.
1ELX's Gross Margin of 74.18% is amongst the best of the industry. 1ELX outperforms 93.33% of its industry peers.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 74.18%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ELX is destroying value.
Compared to 1 year ago, 1ELX has more shares outstanding
Compared to 5 years ago, 1ELX has less shares outstanding
Compared to 1 year ago, 1ELX has a worse debt to assets ratio.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 3.36 indicates that 1ELX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.36, 1ELX is in line with its industry, outperforming 53.33% of the companies in the same industry.
The Debt to FCF ratio of 1ELX is 7.01, which is on the high side as it means it would take 1ELX, 7.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.01, 1ELX is doing worse than 60.00% of the companies in the same industry.
1ELX has a Debt/Equity ratio of 1.88. This is a high value indicating a heavy dependency on external financing.
1ELX has a Debt to Equity ratio of 1.88. This is amonst the worse of the industry: 1ELX underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Altman-Z 3.36
ROIC/WACC0.62
WACC7.59%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.32. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.32, 1ELX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
1ELX has a Quick Ratio of 1.32. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
1ELX has a better Quick ratio (0.92) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

The earnings per share for 1ELX have decreased strongly by -36.12% in the last year.
The earnings per share for 1ELX have been decreasing by -18.22% on average. This is quite bad
The Revenue has decreased by -6.53% in the past year.
Measured over the past years, 1ELX shows a small growth in Revenue. The Revenue has been growing by 0.04% on average per year.
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%

3.2 Future

The Earnings Per Share is expected to grow by 28.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y47.45%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
EPS Next 5Y28.75%
Revenue Next Year4.25%
Revenue Next 2Y4.16%
Revenue Next 3Y4.41%
Revenue Next 5Y3.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 62.10, the valuation of 1ELX can be described as expensive.
1ELX's Price/Earnings ratio is a bit more expensive when compared to the industry. 1ELX is more expensive than 73.33% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.51, 1ELX is valued quite expensively.
1ELX is valuated quite expensively with a Price/Forward Earnings ratio of 34.05.
1ELX's Price/Forward Earnings ratio is rather expensive when compared to the industry. 1ELX is more expensive than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, 1ELX is valued a bit more expensive.
Industry RankSector Rank
PE 62.1
Fwd PE 34.05
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued expensively inside the industry as 86.67% of the companies are valued cheaper.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.86
EV/EBITDA 20.46
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1ELX's earnings are expected to grow with 36.61% in the coming years.
PEG (NY)1.31
PEG (5Y)N/A
EPS Next 2Y42.7%
EPS Next 3Y36.61%

2

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.30%. Purely for dividend investing, there may be better candidates out there.
1ELX's Dividend Yield is slightly below the industry average, which is at 2.12.
1ELX's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of 1ELX has a limited annual growth rate of 4.31%.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1ELX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of 1ELX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-54.3%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (12/9/2025, 7:00:00 PM)

88.8

+0.8 (+0.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners91.7%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap32.00B
Revenue(TTM)14.44B
Net Income(TTM)-930.00M
Analysts71.11
Price Target86.68 (-2.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend1.47
Dividend Growth(5Y)4.31%
DP-54.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.2%
Min EPS beat(2)0.44%
Max EPS beat(2)75.96%
EPS beat(4)4
Avg EPS beat(4)65.82%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)73.78%
EPS beat(12)11
Avg EPS beat(12)86.84%
EPS beat(16)15
Avg EPS beat(16)68.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)1
Avg Revenue beat(12)-1.68%
Revenue beat(16)2
Avg Revenue beat(16)-1.82%
PT rev (1m)6.95%
PT rev (3m)19.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.13%
EPS NY rev (1m)0.49%
EPS NY rev (3m)-0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 62.1
Fwd PE 34.05
P/S 2.59
P/FCF 35.86
P/OCF 23.39
P/B 9.63
P/tB N/A
EV/EBITDA 20.46
EPS(TTM)1.43
EY1.61%
EPS(NY)2.61
Fwd EY2.94%
FCF(TTM)2.48
FCFY2.79%
OCF(TTM)3.8
OCFY4.27%
SpS34.22
BVpS9.22
TBVpS-4.58
PEG (NY)1.31
PEG (5Y)N/A
Graham Number17.22
Profitability
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROCE 8.84%
ROIC 4.69%
ROICexc 5.55%
ROICexgc 10.76%
OM 8.72%
PM (TTM) N/A
GM 74.18%
FCFM 7.24%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexgc growth 3Y-33.25%
ROICexgc growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Debt/EBITDA 3.52
Cap/Depr 67.84%
Cap/Sales 3.86%
Interest Coverage 3.58
Cash Conversion 76.98%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.92
Altman-Z 3.36
F-Score5
WACC7.59%
ROIC/WACC0.62
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
EPS Next Y47.45%
EPS Next 2Y42.7%
EPS Next 3Y36.61%
EPS Next 5Y28.75%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%
Revenue Next Year4.25%
Revenue Next 2Y4.16%
Revenue Next 3Y4.41%
Revenue Next 5Y3.86%
EBIT growth 1Y-21.3%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year106.84%
EBIT Next 3Y38.64%
EBIT Next 5Y27.48%
FCF growth 1Y171.62%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-18.8%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%

ESTEE LAUDER COMPANIES-CL A / 1ELX.MI FAQ

What is the ChartMill fundamental rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI.


What is the valuation status for 1ELX stock?

ChartMill assigns a valuation rating of 1 / 10 to ESTEE LAUDER COMPANIES-CL A (1ELX.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTEE LAUDER COMPANIES-CL A?

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a profitability rating of 3 / 10.


What is the valuation of ESTEE LAUDER COMPANIES-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 62.1 and the Price/Book (PB) ratio is 9.63.


How sustainable is the dividend of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

The dividend rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 2 / 10 and the dividend payout ratio is -54.3%.